Company intelligence / Profile preview

KUR Research

Dallas, Texas, United Stateskurr.com ↗

Ownership: Private
Development stage: Other

Overview

KUR Research is an integrated clinical research site network with over 10 years of experience. It has completed hundreds of clinical trials—including more than 100 medical device and diagnostic studies—with over 10,000 volunteers enrolled and high retention rates. The company partners with community-based private practices, urgent care centers, and specialists to provide rapid enrollment of diverse patient populations. Additionally, KUR is developing one of the largest geographically diverse infectious disease BioBanks in the United States.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnosticSmall moleculeBiologic
Industry: Contract Research Organization

Partnerships

Numerous sponsors across pharma/biotech/device sectors

Beyond the preview

Go deeper on KUR Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KUR Research.

Explore the full profile